AI assistant
ANAGENICS LIMITED — Director's Dealing 2019
May 5, 2019
64383_rns_2019-05-05_129f15bc-b248-408c-9122-d33a5efdd85c.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
| Name of entity | Cellmid Limited |
|---|---|
| ABN | 69 111 304 119 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Ms Maria Halasz |
|---|---|
| Date of last notice | 18 April 2019 |
Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Direct and Indirect |
|---|---|
| Nature of indirect interest | Direct Capital Group Pty Ltd and Direct Capital Pty |
| (including registered holder)Note: Provide details of the circumstances giving rise to the | Ltd – Entities controlled by the Director |
| relevant interest. | |
| Date of change | 29 April 2019 |
| No. of securities held prior to change | Direct |
| 420,000 fully paid ordinary shares | |
| Indirect | |
| 1,548,938fully paid ordinaryshares | |
| Class | Fully paid ordinary shares |
| Number acquired | 39,000 |
| Number disposed | Nil |
| Value/Consideration | $0.21 per share (total value of $8,190) |
| Note: If consideration is non-cash, provide details and | |
| estimated valuation |
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held after change | Direct |
|---|---|
| 420,000 fully paid ordinary shares | |
| Indirect | |
| 1,587,938 fully paid ordinary shares | |
| Nature of change | On-market purchase |
| Example: on-market trade, off-market trade, exercise of | |
| options, issue of securities under dividend reinvestment | |
| plan, participation in buy-back |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder | N/A |
| (if issued securities) | |
| Date of change | N/A |
| No. and class of securities to which | N/A |
| interest related prior to change | |
| Note: Details are only required for a contract in relation to | |
| which the interest has changed | |
| Interest acquired | N/A |
| Interest disposed | N/A |
| Value/Consideration | N/A |
| Note: If consideration is non-cash, provide details and an | |
| estimated valuation | |
| Interest after change | N/A |
Part 3 –[+] Closed period
| Part 3 –+Closed period | |
|---|---|
| Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required? | No |
| If so, was prior written clearance provided to allow the tradeto proceed during this period? | N/A |
| If prior written clearance was provided, on what date was thisprovided? | N/A |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011